• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy.

作者信息

Oshikiri Taro, Numasaki Hodaka, Oguma Junya, Toh Yasushi, Watanabe Masayuki, Muto Manabu, Kakeji Yoshihiro, Doki Yuichiro

机构信息

Division of Gastrointestinal Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Ann Surg Oncol. 2023 May;30(5):2699-2700. doi: 10.1245/s10434-022-12892-4. Epub 2023 Jan 11.

DOI:10.1245/s10434-022-12892-4
PMID:36629993
Abstract
摘要

相似文献

1
ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy.ASO作者反思：对于接受新辅助放化疗后行食管切除术的食管鳞状细胞癌患者，保留胸导管是可行的。
Ann Surg Oncol. 2023 May;30(5):2699-2700. doi: 10.1245/s10434-022-12892-4. Epub 2023 Jan 11.
2
Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan.对于接受新辅助放化疗的食管鳞状细胞癌患者，是否有必要进行胸导管切除术？基于日本食管癌综合登记处的倾向匹配分析。
Ann Surg Oncol. 2023 May;30(5):2691-2698. doi: 10.1245/s10434-022-12891-5. Epub 2022 Dec 18.
3
ASO Author Reflections: Exploring the Best Parameter for Lymph Node Assessment in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.《血管外科学年鉴》作者反思：探索新辅助放化疗后食管鳞状细胞癌患者淋巴结评估的最佳参数
Ann Surg Oncol. 2024 Feb;31(2):899-900. doi: 10.1245/s10434-023-14189-6. Epub 2023 Nov 25.
4
Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.新辅助放化疗后行胸导管切除术的微创食管癌切除术——对淋巴结获取量和血流动力学参数的影响
J Gastrointest Cancer. 2019 Jun;50(2):230-235. doi: 10.1007/s12029-018-0051-1.
5
ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.ASO作者反思：新辅助治疗后接受食管鳞状细胞癌次全食管切除术患者的术前凝血状态与预后之间的关联
Ann Surg Oncol. 2024 May;31(5):3473-3474. doi: 10.1245/s10434-024-14979-6. Epub 2024 Jan 23.
6
ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌新辅助放化疗的生物标志物
Ann Surg Oncol. 2018 Dec;25(Suppl 3):715-716. doi: 10.1245/s10434-018-6837-3. Epub 2018 Oct 4.
7
ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study.ASO作者反思：食管鳞状细胞癌患者的新辅助化疗或新辅助放化疗：来自日本全国性研究的真实世界数据比较
Ann Surg Oncol. 2023 Sep;30(9):5895-5896. doi: 10.1245/s10434-023-13687-x. Epub 2023 Jun 2.
8
ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌手术与放化疗的时机
Ann Surg Oncol. 2023 Apr;30(4):2224-2225. doi: 10.1245/s10434-022-13048-0. Epub 2023 Jan 6.
9
Significance of Thoracic Duct Resection During Esophagectomy for Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌食管癌切除术中胸导管切除术的意义
Ann Surg Oncol. 2023 May;30(5):2582-2583. doi: 10.1245/s10434-022-13060-4. Epub 2023 Jan 23.
10
ASO Author Reflections: Timing of Oesophagectomy After Neoadjuvant Chemoradiotherapy for Locally Advanced Oesophageal Cancer.ASO作者反思：局部晚期食管癌新辅助放化疗后食管切除术的时机
Ann Surg Oncol. 2023 Feb;30(2):897-898. doi: 10.1245/s10434-022-12774-9. Epub 2022 Nov 2.

本文引用的文献

1
The Influence of Preoperative Smoking Status on Postoperative Complications and Long-Term Outcome Following Thoracoscopic Esophagectomy in Prone Position for Esophageal Carcinoma.术前吸烟状况对食管癌俯卧位胸腔镜食管切除术后并发症及长期预后的影响
Ann Surg Oncol. 2023 Apr;30(4):2202-2211. doi: 10.1245/s10434-022-12898-y. Epub 2022 Dec 20.
2
Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.常规胸导管切除术后食管癌患者的预后：基于日本食管癌综合登记数据库的 12237 例患者倾向性匹配分析。
Ann Surg. 2023 May 1;277(5):e1018-e1025. doi: 10.1097/SLA.0000000000005340. Epub 2023 Apr 6.
3
Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.胸导管切除术在食管癌中的应用并未改善食管鳞癌患者的预后：一项倾向评分匹配队列研究。
Ann Surg Oncol. 2019 Nov;26(12):4053-4061. doi: 10.1245/s10434-019-07627-x. Epub 2019 Jul 16.